Explorer les evidences

4,4 %Sacubitril–valsartan was prescribed to 25 women (4.4%) and 101 men (6.8%) in the HFrEF subgroup.

TunisieHFrEFHAL · Unilimdocument de 95 observations

50 %Approximately 50% of individuals with diabetes in Tunisia are still undiagnosed.

Tunisiediabète (non précisé)HAL · Unilimdocument de 9 observations

60,7 %In the HFrEF subgroup, mineralocorticoid receptor antagonists (MRA) were prescribed to 342 women (60.7%) and 910 men (61.6%).

TunisieHFrEFHAL · Unilimdocument de 95 observations

60 %La prévalence de l'anticorps anti-HCV est de 60,0 % chez les patients atteints de carcinome hépatocellulaire en Tunisie et au Maroc (étude menée entre 2002 et 2005).

Tunisiecarcinome hépatocellulaire · hépatite Cobservé 2002 à 2005HAL · Unilimdocument de 199 observations

27,4 %Atrial fibrillation prevalence was significantly higher in women (27.4%) than in men (11.8%) in the Tunisian cohort of the MEA-WCVD registry.

Tunisieatrial fibrillationHAL · Unilimdocument de 95 observations

6,8 %Sacubitril–valsartan was prescribed to 101 men (6.8%) and 25 women (4.4%) in the HFrEF subgroup.

TunisieHFrEFHAL · Unilimdocument de 95 observations

5 casesThe incidence of imported malaria cases in Tunisia showed a gradually increasing trend from 5 cases in 2008 to 56 cases in 2022.

Tunisiepaludismeobservé 2008HAL · Unilimdocument de 123 observations

17,9 %La prévalence de l'antigène HBsAg est de 17,9 % chez les patients atteints de carcinome hépatocellulaire en Tunisie et au Maroc (étude menée entre 2002 et 2005).

Tunisiecarcinome hépatocellulaire · hépatite Bobservé 2002 à 2005HAL · Unilimdocument de 199 observations

3 400 000 deaths_per_yearDiabetes causes more than 3.4 million deaths per year globally.

Tunisiediabète (non précisé)HAL · Unilimdocument de 9 observations